Recent advancements show that redox-responsive nanoparticles carrying p53 mRNA effectively reduced viability in p53-null lung cancer cells and significantly decreased tumor size in HCC and NSCLC mouse models. This evidence concerns the gene TP53 and non-small cell lung carcinoma.